Epigenetic mechanisms act at the interface between genetics and environment and are an important determinant in disease risk to complex human diseases such as cancer or autism. This proposal employs a combination of systems and approaches that focus on the central question of the impact of persistent environmental pollutants (POPs) on precise epigenetic changes that occur in neurodevelopmental disorders. The widespread prevalence of POPs such as polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs) in the environment and their detection in human milk has prompted concern about in utero and early infant exposure to these compounds. Perinatal exposure to PCBs and PBDEs in rats results in long-lasting defects in learning, memory, behavior, and seizure susceptibility in adulthood. Epigenetic changes to the genome as a result of PCB and PBDE exposures have not been previously explored but are a plausible explanation for the long-lasting effects on neuropsychological function. This proposal will focus specifically on two compounds, PCB 95 and PBDE 47, with high levels in humans and known effects on neurodevelopment. The genetically controlled component of the proposed studies will be to use a genetically engineered Mecp2 mutant mouse model of Rett syndrome and autism. In additional to animal studies, human blood and post-mortem brain samples from individuals with autism, mental retardation, and controls will be tested for precise epigenetic changes in three neurodevelopmentally important genes (MECP2, GABRB3, UBE3A). Since PCB and PBDE levels will be determined in these human samples, correlations of exposures to epigenetic changes can be performed. Several public health relevant questions will be addressed by these studies: What specific epigenetic changes to neurodevelopmentally important genes occur as a result of POP exposure? What is the compounding effect of known genetic and environmental factors in the etiology of autism and mental retardation? Can specific epigenetic changes be diagnostic for autism and mental retardation of unknown genetic etiology? Are epigenetic changes affecting neurodevelopment heritable?

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
3R01ES015171-04S1
Application #
7918624
Study Section
Special Emphasis Panel (ZES1-LWJ-E (EP))
Program Officer
Tyson, Frederick L
Project Start
2009-09-17
Project End
2010-09-16
Budget Start
2009-09-17
Budget End
2010-09-16
Support Year
4
Fiscal Year
2009
Total Cost
$67,208
Indirect Cost
Name
University of California Davis
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Selmi, C; Feghali-Bostwick, C A; Lleo, A et al. (2012) X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma. Clin Exp Immunol 169:253-62
Mitchell, Michelle M; Woods, Rima; Chi, Lai-Har et al. (2012) Levels of select PCB and PBDE congeners in human postmortem brain reveal possible environmental involvement in 15q11-q13 duplication autism spectrum disorder. Environ Mol Mutagen 53:589-98
Woods, Rima; Vallero, Roxanne O; Golub, Mari S et al. (2012) Long-lived epigenetic interactions between perinatal PBDE exposure and Mecp2308 mutation. Hum Mol Genet 21:2399-411
Scoles, Haley A; Urraca, Nora; Chadwick, Samuel W et al. (2011) Increased copy number for methylated maternal 15q duplications leads to changes in gene and protein expression in human cortical samples. Mol Autism 2:19
Mitchell, Michelle M; Lleo, Ana; Zammataro, Luca et al. (2011) Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis. Epigenetics 6:95-102
Schroeder, Diane I; Lott, Paul; Korf, Ian et al. (2011) Large-scale methylation domains mark a functional subset of neuronally expressed genes. Genome Res 21:1583-91
LaSalle, Janine M (2011) A genomic point-of-view on environmental factors influencing the human brain methylome. Epigenetics 6:862-9
Magby, Jason P; Neal, April P; Atchison, William D et al. (2011) Channelopathies: summary of the hot topic keynotes session. Neurotoxicology 32:661-5
Kim, Kyung Ho; Bose, Diptiman D; Ghogha, Atefeh et al. (2011) Para- and ortho-substitutions are key determinants of polybrominated diphenyl ether activity toward ryanodine receptors and neurotoxicity. Environ Health Perspect 119:519-26
Yasui, Dag H; Scoles, Haley A; Horike, Shin-Ichi et al. (2011) 15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain. Hum Mol Genet 20:4311-23

Showing the most recent 10 out of 13 publications